EUCOMED (European Confederation of Medical Device Suppliers Association) human tissue directive by mid-2001:
This article was originally published in Clinica
Executive Summary
A task force at the European medical device association, EUCOMED, aims to present firm proposals for a directive on devices incorporating human tissues by the middle of next year. The group, which met on November 29, does not believe that such products should fall under the medicinal products regime, except where the primary mode of action is clearly intended to be pharmacological. EUCOMED continues to believe that this legislation should be based on a risk/benefit approach with the level of control commensurate with the risk, and that it should cover sourcing, procurement and ethical issues, as well as manufacturing and aspects relating to its placing on the market.
You may also be interested in...
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at Vigil Neuroscience and Voyager Therapeutics.
Israel's Gamida Cell Survives By Selling To Lender
Having finally secured US approval for Omisirge, Gamida was hoping to bag a strategic partner for the cell therapy. A year on, no suitable partner has been identified and the firm is delisting from the NASDAQ and going private.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.